Prothrombin Complex Concentrate Market Industry Overview, Size, Share, Growth Trends, Research Insights and Forecast (2025–2032)

Prothrombin Complex Concentrate Market was estimated at USD 2.30 Bn in 2024 and is expected to grow at a CAGR of 9.6% from 2025 to 2032, reaching nearly USD 4.8 Bn by 2032.

Format : PDF | Report ID : SMR_2708

Prothrombin Complex Concentrate Market Overview

Prothrombin Complex Concentrate (PCC) is a medication derived from human plasma that contains a mixture of vitamin K dependent coagulation factors (II, VII, IX, and X), primarily used for the rapid reversal of vitamin K antagonist (like warfarin) therapy and to treat bleeding in certain conditions.

The market is rising because of a rise in the occurrence of hemorrhage disorders like hemophilia, acquired hemorrhagic disorders, and vitamin deficiency. According to global population data from the World Federation of Haemophilia, about 400,000 people are suffering from the disease, while about 75% of patients are underlined, mainly in developing countries, the Prothrombin Complex is running the Complex Concentrate Market.

Additionally, extended slightly enlarged populations and high growth of blood thinness also promotes the demand for complex focus. Due to the use of warfarin, the demand for Prothrombin Complex concept increases considerably. It acts as a blood thinner and it increases the risk of bleeding, while the prothrombin complex focused normal blood clotting function. The North America Prothrombin Complex concentrate in the Global Market holds a great market share based on the appearance of the complex concentrate dominant manufacturers and the 4-Factor drug approval. In Europe, there is a growing use of 4-factor Prothrombin Complex Concentrate products and favourable policies for reimbursement of medical expenses.

Prothrombin Complex Concentrate Market snapshot

To get more Insights: Request Free Sample Report

Prothrombin Complex Concentrate Market Dynamics

Growth of Bleeding Disorders to Fuel the Prothrombin Complex Concentrate Market

The increasing of blood disorders such as haemophilia, liver diseases, and warfarin associated bleeding risk Boosting the Prothrombin Complex Concentrate Market. The rise in the number of surgical procedure and trauma cases that need immediate coagulation support is driving the Prothrombin Complex Concentrate industry. The growing emphasis on personalized medicine and targeted coagulation therapies is likely to shape future trends in the Prothrombin Complex Concentrate Market. In addition, increasing incidence of cardiovascular procedures, increased population of geriatric people and improper utilization of anticoagulants are also the growth drivers for the market.

Technology Advancement in Coagulation Therapies to Create Opportunities in Prothrombin Complex Concentrate Market

Coagulation therapies and the invention of new formulations with enhanced safety and efficacy are making the possibilities. Prothrombin Complex Concentrate is obtained from human plasma through the method of Cohn fractionation and chromatographic purification, a widely applied method to separate the concentrate coagulation factors. Infrastructure development is encouraging increased access to the Prothrombin Complex Concentrate Market. Moreover, the increasing use of the prothrombin complex instead of fresh frozen plasma, as its fast start of its action is in support of the expansion of the market.

The Prothrombin Complex Concentrate Market Faces Restraints Related to the High Cost of the Product

The low level of product pricing and lack of awareness of the therapeutic effect in some parts limit the Prothrombin Complex Concentrate Market. Thromboembolic events associated with Prothrombin Complex Concentrate use have resulted in the cautious use in some clinical contexts. Additionally, regulatory rules and stringent new product approval processes are hindering new market growth for new participants.

Prothrombin Complex Concentrate Market Segment Analysis

Based on product type, the Market is segmented into 3-factor and 4-factor Prothrombin Complex Concentrate. The 4-factor segment dominated the market in 2024 and is expected to hold the largest Prothrombin Complex Concentrate Market share over the forecast period (2024-2032). The 4-factor Prothrombin Complex Concentrate is predominantly the health organizations' recommendation. It is also the recommendation for warfarin reversal of the direct oral anticoagulants in critical conditions. The 4-factors containing II, VII, IX, and X with Protein C and S are majorly used due to its warfarin-reversing effectiveness. Additionally, the 4-factor prothrombin complex concentrate is preferable due to its fast and total reversal of anticoagulation, which renders it as a first-line therapy in life-threatening cases of bleeding.

By Application type, the Prothrombin Complex Concentrate Market is segmented into acquired coagulation factor deficiency, congenital coagulation factor deficiency, and other applications. The acquired coagulation factor deficiency segment dominated the market in 2024 and is expected to hold the largest market share over the forecast period (2024-2032). Acquired coagulation factor deficiency is mainly found in trauma and surgery, which require immediate management. The Prothrombin Complex Concentrate is used mainly in these conditions in an emergency to increase hemostasis. In addition, with an increase in the number of elderly patients, which are undergoing complex surgery and painful injuries, especially in important care and emergency, the Prothrombin Complex Concentrate continues to increase the market demand. Physicians have a priority for PCC on options such as plasma because its sharp infusion rate is required in small amounts, and low risk for volume overload, a useful feature in emergency medical and intensive care.

Based on End-use, the prothrombin complex concentrate market is segmented into hospitals, ambulatory surgical centres, and other end-users. The Hospital segment dominated the market in 2024 and is expected to hold the largest market share over the forecast period (2024-2032). In this, the hospital section will lead the market in 2024 and will increase by 2.4 billion by 2032. Hospitals are often the starting point of treatment for patients with severe hemorrhage or which require immediate reversal of anticoagulants. Essential infrastructure, such as professional employees and inventive technology, facilitates care of patients with serious medical conditions. This ability handled the adverse effects these factors enhance the growth of this segment.

Prothrombin Complex Concentrate Market Regional Analysis

North America segment dominated the market in 2024 and is expected to hold the largest market share over the forecast period (2024-2032)

The Advanced healthcare infrastructure in the U.S. and Canada supports the effective administration and monitoring of Prothrombin Complex Concentrate. The increased number of cardiovascular diseases, trauma cases, and warfarin use has driven the North American regions Market. There is a clear increase in health care expenses in the US, such as biotechnology, as well as novel treatment for coagulation issues. The United States has experienced significant increase in healthcare expenses, especially in areas such as biotechnology, emergency medical and innovative medical solutions for coagulation disorders. This trend validates the creation and implementation of advanced treatments like PCC. Europe also represents a major market share with Germany, France and Britain that is due to their high-developed healthcare system.

Prothrombin Complex Concentrate Market by Region

Prothrombin Complex Concentrate Market Competitive Landscape

Prothrombin complex concentrate market players are mainly focused on product innovation, strategic cooperation and geographical expansion to establish their market footprint. Major players including CSL Behring, Grifols S.A., Octapharma AG are well -established Prothrombin Complex Concentrate products and hold large market share due to their safety and efficacy and availability worldwide. Healthcare is dominating North America and Europe markets for managing leading due to infrastructure and high prothrombin complexes. Hospital and Trauma Center Partnership is beneficial to increase the availability of Prothrombin Complex concentrate products.

Prothrombin Complex Concentrate Market Top Key Players

Prothrombin Complex Concentrate Market Scope
Market Size in 2024	USD 2.30 Bn.
Market Size in 2032	USD 4.8 Bn.
CAGR (2024-2032)	9.6%
Historic Data	2019-2024
Base Year	2024
Forecast Period	2024-2032
Segments	By Product 4-factor PCC 3-factor PCC
	By Application Acquired coagulation factor deficiency Congenital coagulation factor deficiency
	By End-user Hospitals Ambulatory surgical centres Others
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, South Korea, Japan, India, Australia, Indonesia, Philippines, Malaysia, Vietnam, Thailand, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

Key Players of Prothrombin Complex Concentrate Market

North America:

CSL Behring (USA)
Grifols, S.A. (USA)
Kedrion S.p.A. (USA)
Shire (USA)
Takeda Pharmaceutical Company Limited (USA)
Biotest AG (USA)

Europe:

Octapharma AG (Switzerland)
LFB Biomedicaments S.A. (France)
Sanquin (Netherlands)
Mitsui Chemicals, Inc. (Japan)
Kedrion S.p.A. (Italy)

Asia-Pacific:

Beijing Tiantan Biological Products Co., Ltd. (China)
Hualan Biological Engineering Inc. (China)
Weiguang Biology (South Korea)
Green Cross (China) Biological Products Co., Ltd. (China)
Guangdong Shuanglin Biopharmaceutical Co., Ltd. (China)
Jiangxi Boya Biopharmaceutical Co., Ltd. (China)

Buy Now

Request For Free sample

Frequently Asked Questions

1. Which region has the largest share in the Prothrombin Complex Concentrate Market?

The North America region held the highest share in 2024.

2. Who are the key competitors in the Prothrombin Complex Concentrate Market

CSL Behring, Grifols S.A., Octapharma AG are the top competitors in the Prothrombin Complex Concentrate Market.

3. What are the key factors driving the growth of the Prothrombin Complex Concentrate Market?

The growth of blood disorders like haemophilia, liver diseases, and warfarin-related bleeding risk driving the growth of the Prothrombin Complex Concentrate Market.

4. What are the major challenges facing the Prothrombin Complex Concentrate Market?

The high cost of the product and the limited awareness about the therapeutic benefit in certain regions are the major challenges facing the Prothrombin Complex Concentrate Market.

5. Which product type dominates the Prothrombin Complex Concentrate Market?

The 4-factor segment product type dominated the market in 2024.

1.   Prothrombin Complex Concentrate Market Introduction
1.1.   Study Assumption and Market Definition
1.2.   Scope of the Study
1.3.   Executive Summary

2.   Global Prothrombin Complex Concentrate Market: Competitive Landscape
2.1.   SMR Competition Matrix
2.2.   Competitive Landscape
2.3.   Key Players Benchmarking
2.3.1. Company Name
2.3.2. Product Segment
2.3.3. End-user Segment
2.3.4. Revenue (2024)
2.4.   Leading Prothrombin Complex Concentrate Market Companies, by Market Capitalization
2.5.   Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6.   Mergers and Acquisitions Details

3.   Prothrombin Complex Concentrate Market: Dynamics
3.1.   Prothrombin Complex Concentrate Market Trends by Region
3.1.1. North America Prothrombin Complex Concentrate Market Trends
3.1.2. Europe Prothrombin Complex Concentrate Market Trends
3.1.3. Asia Pacific Prothrombin Complex Concentrate Market Trends
3.1.4. Middle East & Africa Prothrombin Complex Concentrate Market rends
3.1.5. South America Prothrombin Complex Concentrate Market Marke Trends
3.2.   Prothrombin Complex Concentrate Market Dynamics by Global
3.3.   PORTER’s Five Forces Analysis
3.4.   PESTLE Analysis
3.5.   Value Chain Analysis
3.6.   Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East & Africa
3.6.5. South America

4.   Prothrombin Complex Concentrate Market: Global Market Size and Forecast by Segmentation (by Value USD Bn) (2024-2032)
4.1.   Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
4.1.1. 3-factor PCC
4.1.2. 4-factor PCC
4.2.   Prothrombin Complex Concentrate Market Size and Forecast, By Application (2024-2032)
4.2.1. Aquired coagulation factor deficiency
4.2.2. Congential coagulation factor deficiency
4.3.   Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
4.3.1. Hospital
4.3.2. Ambulatory Surgical Centres
4.3.3. Others
4.4.   Prothrombin Complex Concentrate Market Size and Forecast, By Region (2024-2032)
4.4.1. North America
4.4.2. Europe
4.4.3. Asia Pacific
4.4.4. Middle East & Africa
4.4.5. South America

5.   North America Prothrombin Complex Concentrate Market Size and Forecast by Segmentation (by Value USD Bn) (2024-2032)
5.1.   North America Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
5.1.1. 3-factor PCC
5.1.2. 4-factor PCC
5.2.   North America Prothrombin Complex Concentrate Market Size and Forecast, By Application (2024-2032)
5.2.1. Aquired coagulation factor deficiency
5.2.2. Congential coagulation factor deficiency
5.3.   North America Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
5.3.1. Hospital
5.3.2. Ambulatory Surgical Centres
5.3.3. Others
5.4.   North America Prothrombin Complex Concentrate Market Size and Forecast, by Country (2024-2032)
5.4.1. United States
5.4.1.1. United States Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
5.4.1.1.1. 3-factor PCC
5.4.1.1.2. 4-factor PCC
5.4.1.2. United States United States Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
5.4.1.2.1. Aquired coagulation factor deficiency
5.4.1.2.2. Congential coagulation factor deficiency
5.4.1.3. United States Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
5.4.1.3.1. Hospital
5.4.1.3.2. Ambulatory Surgical Centres
5.4.1.3.3. Others
5.4.2. Canada
5.4.2.1. Canada Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
5.4.2.1.1. 3-factor PCC
5.4.2.1.2. 4-factor PCC
5.4.2.2. Canada Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
5.4.2.2.1. Aquired coagulation factor deficiency
5.4.2.2.2. Congential coagulation factor deficiency
5.4.2.3. Canada Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
5.4.2.3.1. Hospital
5.4.2.3.2. Ambulatory Surgical Centres
5.4.2.3.3. Others
5.4.3. Mexico
5.4.3.1. Mexico Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
5.4.3.1.1. 3-factor PCC
5.4.3.1.2. 4-factor PCC
5.4.3.2. Mexico Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
5.4.3.2.1. Aquired coagulation factor deficiency
5.4.3.2.2. Congential coagulation factor deficiency
5.4.3.3. Mexico Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
5.4.3.3.1. Hospital
5.4.3.3.2. Ambulatory Surgical Centres
5.4.3.3.3. Others

6.   Europe Prothrombin Complex Concentrate Market Size and Forecast by Segmentation (by Value USD Bn) (2024-2032)
6.1.   Europe Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.2.   Europe Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.3.   Europe Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.   Europe Prothrombin Complex Concentrate Market Size and Forecast, by Country (2024-2032)
6.4.1. United Kingdom
6.4.1.1. United Kingdom Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.1.2. United Kingdom Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.1.3. United Kingdom Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.2. France
6.4.2.1. France Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.2.2. France Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.2.3. France Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.3. Germany
6.4.3.1. Germany Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.3.2. Germany Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.3.3. Germany Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.4. Italy
6.4.4.1. Italy Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.4.2. Italy Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.4.3. Italy Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.5. Spain
6.4.5.1. Spain Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.5.2. Spain Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.5.3. Spain Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.6. Sweden
6.4.6.1. Sweden Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.6.2. Sweden Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.6.3. Sweden Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.7. Austria
6.4.7.1. Austria Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.7.2. Austria Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.7.3. Austria Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
6.4.8.2. Rest of Europe Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
6.4.8.3. Rest of Europe Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)

7.   Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast by Segmentation (by Value USD Bn) (2024-2032)
7.1.   Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.2.   Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.3.   Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.   Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, by Country (2024-2032)
7.4.1. China
7.4.1.1. China Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.1.2. China Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.1.3. China Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.2. S Korea
7.4.2.1. S Korea Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.2.2. S Korea Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.2.3. S Korea Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.3. Japan
7.4.3.1. Japan Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.3.2. Japan Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.3.3. Japan Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.4. India
7.4.4.1. India Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.4.2. India Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.4.3. India Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.5. Australia
7.4.5.1. Australia Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.5.2. Australia Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.5.3. Australia Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.6. Indonesia
7.4.6.1. Indonesia Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.6.2. Indonesia Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.6.3. Indonesia Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.7. Philippines
7.4.7.1. Philippines Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.7.2. Philippines Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.7.3. Philippines Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.8. Malaysia
7.4.8.1. Malaysia Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.8.2. Malaysia Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.8.3. Malaysia Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.9. Vietnam
7.4.9.1. Vietnam Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.9.2. Vietnam Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.9.3. Vietnam Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.10. Thailand
7.4.10.1. Thailand Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.10.2. Thailand Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.10.3. Thailand Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.11. ASEAN
7.4.11.1. ASEAN Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.11.2. ASEAN Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.11.3. ASEAN Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
7.4.12. Rest of Asia Pacific
7.4.12.1. Rest of Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
7.4.12.2. Rest of Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
7.4.12.3. Rest of Asia Pacific Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)

8.   Middle East and Africa Prothrombin Complex Concentrate Market Size and Forecast by Segmentation (by Value USD Bn) (2024-2032)
8.1.   Middle East and Africa Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
8.2.   Middle East and Africa Prothrombin Complex Concentrate Market Size and Forecast, By Applications Model (2024-2032)
8.3.   Middle East and Africa Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
8.4.   Middle East and Africa Prothrombin Complex Concentrate Market Size and Forecast, by Country (2024-2032)
8.4.1. South Africa
8.4.1.1. South Africa Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
8.4.1.2. South Africa Prothrombin Complex Concentrate Market Size and Forecast, By Applications Model (2024-2032)
8.4.1.3. South Africa Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
8.4.2. GCC
8.4.2.1. GCC Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
8.4.2.2. GCC Prothrombin Complex Concentrate Market Size and Forecast, By Applications Model (2024-2032)
8.4.2.3. GCC Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
8.4.3. Nigeria
8.4.3.1. Nigeria Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
8.4.3.2. Nigeria Prothrombin Complex Concentrate Market Size and Forecast, By Applications Model (2024-2032)
8.4.3.3. Nigeria Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
8.4.4. Rest of ME&A
8.4.4.1. Rest of ME&A Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
8.4.4.2. Rest of ME&A Prothrombin Complex Concentrate Market Size and Forecast, By Applications Model (2024-2032)
8.4.4.3. Rest of ME&A Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)

9.   South America Prothrombin Complex Concentrate Market Size and Forecast by Segmentation (by Value USD Bn.) (2024-2032)
9.1.   South America Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
9.2.   South America Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
9.3.   South America Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
9.4.   South America Prothrombin Complex Concentrate Market Size and Forecast, by Country (2024-2032)
9.4.1. Brazil
9.4.1.1. Brazil Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
9.4.1.2. Brazil Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
9.4.1.3. Brazil Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
9.4.2. Argentina
9.4.2.1. Argentina Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
9.4.2.2. Argentina Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
9.4.2.3. Argentina Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)
9.4.3. Rest Of South America
9.4.3.1. Rest Of South America Prothrombin Complex Concentrate Market Size and Forecast, By Product (2024-2032)
9.4.3.2. Rest Of South America Prothrombin Complex Concentrate Market Size and Forecast, By Applications (2024-2032)
9.4.3.3. Rest Of South America Prothrombin Complex Concentrate Market Size and Forecast, By End-user (2024-2032)

10.   Company Profile: Key Players
10.1 CSL Behring
10.1.1   Company Overview
10.1.2   Business Portfolio
10.1.3   Financial Overview
10.1.4   SWOT Analysis
10.1.5   Strategic Analysis
10.1.6   Recent Developments
10.2 Grifols, S.A.
10.3 Kedrion S.p.A.
10.4 Shire
10.5 Takeda Pharmaceutical Company Limited
10.6 Biotest AG
10.7 Octapharma AG
10.8 LFB Biomedicaments S.A.
10.9 Sanquin
10.10 Mitsui Chemicals, Inc.
10.11 Kedrion S.p.A.
10.12 Beijing Tiantan Biological Products Co., Ltd.
10.13 Hualan Biological Engineering Inc.
10.14 Weiguang Biology
10.15 Green Cross (China) Biological Products Co., Ltd.
10.16 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
10.17 Jiangxi Boya Biopharmaceutical Co., Ltd.